- Home
- SWAG vs FBIOP Comparison
SWAG vs FBIOP Comparison
Compare SWAG & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWAG
- FBIOP
- Stock Information
- Founded
- SWAG 1994
- FBIOP N/A
- Country
- SWAG United States
- FBIOP United States
- Employees
- SWAG N/A
- FBIOP 101
- Industry
- SWAG Advertising
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- SWAG Consumer Discretionary
- FBIOP Health Care
- Exchange
- SWAG Nasdaq
- FBIOP Nasdaq
- Market Cap
- SWAG N/A
- FBIOP N/A
- IPO Year
- SWAG 2021
- FBIOP N/A
- Fundamental
- Price
- SWAG $1.62
- FBIOP $7.50
- Analyst Decision
- SWAG
- FBIOP
- Analyst Count
- SWAG 0
- FBIOP 0
- Target Price
- SWAG N/A
- FBIOP N/A
- AVG Volume (30 Days)
- SWAG 98.7K
- FBIOP N/A
- Earning Date
- SWAG 08-12-2025
- FBIOP N/A
- Dividend Yield
- SWAG N/A
- FBIOP N/A
- EPS Growth
- SWAG N/A
- FBIOP N/A
- EPS
- SWAG N/A
- FBIOP N/A
- Revenue
- SWAG $108,405,000.00
- FBIOP N/A
- Revenue This Year
- SWAG N/A
- FBIOP N/A
- Revenue Next Year
- SWAG N/A
- FBIOP N/A
- P/E Ratio
- SWAG N/A
- FBIOP N/A
- Revenue Growth
- SWAG 38.74
- FBIOP N/A
- 52 Week Low
- SWAG $0.73
- FBIOP N/A
- 52 Week High
- SWAG $1.74
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- SWAG 54.58
- FBIOP 50.80
- Support Level
- SWAG $1.37
- FBIOP $6.99
- Resistance Level
- SWAG $1.74
- FBIOP $7.60
- Average True Range (ATR)
- SWAG 0.09
- FBIOP 0.34
- MACD
- SWAG 0.00
- FBIOP 0.06
- Stochastic Oscillator
- SWAG 37.49
- FBIOP 83.65
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.